Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | March 12, 2012

Daubert Motion granted on Price Erosion opinion

Blog | March 09, 2012

EMVR and "Artful Drafting"

Blog | February 14, 2012

Federal Circuit Affirms Ongoing Royalty in Bard v. W.L. Gore

Blog | February 06, 2012

NDCA Addresses Pre-Trial Procedure for Streamlining Patent Marking Defense

Blog | January 10, 2012

NDCA Denies Plaintiff Oracle's Motion for Interlocutory Appeal from $1.3B Copyright Verdict That Was Based on the Novel Theory (in Copyright Cases) of Hypothetical Licensing

Blog | January 06, 2012

EDVA denies motion to stay payment of "sunset" royalties

Blog | January 03, 2012

NDCA clarifies that Marking turns on what claims are asserted, not what survives to trial

Blog | January 02, 2012

NDCA denies Daubert motion for Defendant's damages expert

Article | December 02, 2011

Orange Book Listing Opportunities for Drug-Device Combinations

Blog | December 01, 2011

WD TN Grants New Trial on Damages after Remand Because the Reasonable Royalty Rate in the Original Verdict Was Based on the Now-Defunct 25%

Article | November 08, 2011

Inspiration or infringement?: Examining the Janine Gordon v. Ryan McGinley Photography Case

Article | October 21, 2011

Is It Time for FDA to Revise Its Orange Book Rules to Deal with Skinny Labeled Generic Drugs?